Drug giant Eli Lilly begins the first human trial of its potential COVID-19 antibody treatment

Eli Lilly and Company announced that it has started the first human trial of its potential COVID-19 drug derived from a blood sample of an early US patient who recovered from the illness.

Read More


Sources